Gender differences in treatment response to sertraline versus imipramine in chronic depression.

By S. Kornstein, A. Schatzberg, M. Thase, K. Yonkers, J. P. Mccullough, G. Keitner, A. Gelenberg, S. Davis, W. Harrison, M. Keller. American Journal of Psychiatry, 2000

698 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Pharmacology, Social Psychology

View Paper: https://www.semanticscholar.org/paper/2097dc055a2002f476e22bf5067b17df4d60ec45

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cellular and Molecular Neuroscience

1. M. Peet
2. D. Horrobin

In Pharmacology

1. S. Gilbody
2. M. Peet
3. D. Horrobin

In Social Psychology

1. S. Gilbody
2. M. Altemus

Citations in the corpus

• Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines (2015, background): “While some small to medium studies do suggest that younger women in particular may respond preferentially to SSRIs over noradrenaline reuptake inhibitors (TCAs, maprotiline, duloxetine, reboxetine) (Baca et al., 2004; Berlanga and Flores-Ramos, 2006; Joyce et al., 2002; Kornstein et al., 2000; Marte”
• Sex-Specific Transcriptional Signatures in Human Depression (2017, neutral): “Conversely, overexpression of Emx1 (t(1,5) = 2.”
• Studying sex and gender differences in pain and analgesia: a consensus report. (2007, background): “For example, selective serotonin reuptake inhibitors (SSRIs) are more effective for women than for men for depression [106,197]; research is needed to determine whether this difference holds when SSRIs are used for pain.”
• Sex differences in anxiety and depression clinical perspectives (2014, background): “Several studies have noted better responses to serotonin reuptake inhibiting antidepressants (SSRIs) in women and better response to tricyclic antidepressants in men and older women (Kornstein et al., 2000; Khan et al., 2005), suggesting that inhibition of serotonin reuptake may mitigate the mood-de”
• Evolving knowledge of sex differences in brain structure, function, and chemistry. (2007, background): “It has been suggested hat young women may be more responsive to selective serotoin reuptake inhibitors (SSRIs) versus tricyclic antidepressants ompared with older women and men (68).”